Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00400205 · ClinicalTrials.gov registry record · Phase 2
Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil
A Phase 2 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT00400205 is a Phase 2 study that was terminated before completion, run by Emory University. The registered enrollment target is 14 participants.
The verdict
NCT00400205, a Phase 2 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells.
Interventions
- DRUG Docetaxel
- DRUG Cisplatin
- DRUG 5-fluorouracil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2006-08 |
| Est. Completion | 2009-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00400205
The ClinicalTrials.gov registry entry for NCT00400205 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Docetaxel is the first listed.
NCT00400205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00400205 about?
NCT00400205 is a clinical study titled "Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil". This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells.
What is the current status of trial NCT00400205?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 2006-08. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00400205?
The interventions under investigation include: Docetaxel (DRUG), Cisplatin (DRUG), 5-fluorouracil (DRUG).
Who is sponsoring clinical trial NCT00400205?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.